NCT07584655

Brief Summary

This is a prospective, single-arm, open-label, pilot clinical study to evaluate the efficacy and safety of 10% high-concentration 35 kDa hyaluronan (HA35) gel delivered via gel-soaked cotton balls in patients with gingival pain and swelling after dental procedures. Eligible participants will gently chew and retain the gel-soaked cotton balls on the affected area for 30 minutes. The primary objectives are to assess changes in gingival pain and swelling at 1, 30, and 60 minutes after application. Safety and local oral tolerability will be evaluated throughout the observation period. This is a minimal-risk, non-pharmacological, non-invasive intervention.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Jun 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 13, 2026

Completed
19 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

May 13, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

April 28, 2026

Last Update Submit

May 7, 2026

Conditions

Keywords

Hyaluronan35 kDa HyaluronanHA35Topical GelGingival PainGingival SwellingDental Postoperative CareAnalgesiaAnti-InflammationPilot Clinical Study

Outcome Measures

Primary Outcomes (1)

  • Change in Gingival Pain NRS Score (0-10)

    Change in post-dental gingival pain intensity measured by 0-10 NRS, 0 = no pain, 10 = worst imaginable pain.

    Baseline to 1, 30, and 60 minutes after application

Secondary Outcomes (3)

  • Change in Gingival Swelling Severity (0-10 VAS Score)

    Baseline to 1, 30, and 60 minutes after application

  • Onset Time of Gingival Pain Relief

    Within 60 minutes after application

  • Incidence and Severity of Oral Adverse Events

    Throughout the 60-minute observation period

Study Arms (1)

HA35 Gel Topical Application Group

EXPERIMENTAL

Participants receive 10% high-concentration 35 kDa HA35 gel delivered via gel-soaked cotton balls, which are gently chewed and held in the affected gingival area for 30 minutes to allow sustained local infiltration. Efficacy on gingival pain, swelling, and safety will be evaluated.

Device: 10% High-Concentration 35 kDa Hyaluronan (HA35) Oral Topical Gel

Interventions

Topical oral gel containing 10% high-concentration 35 kDa hyaluronan fragment. Delivered via gel-soaked cotton balls that are gently chewed and retained in the mouth for sustained infiltration into the affected gingival area to relieve post-dental pain and reduce swelling.

Also known as: HA35 Dental Gel, Gingival Care HA35 Gel
HA35 Gel Topical Application Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years, male or female
  • Experienced gingival pain and swelling within 12 hours after dental procedures
  • Baseline gingival pain NRS score ≥2
  • Able to independently complete pain and swelling assessments
  • Signed written informed consent

You may not qualify if:

  • Severe periodontitis, uncontrolled diabetes, or immune dysfunction
  • Long-term use of analgesics or anti-inflammatory drugs
  • Known hypersensitivity to hyaluronan or gel components
  • Oral infection, ulceration, or severe mucosal injury at the application site
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2026

First Posted

May 13, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

May 13, 2026

Record last verified: 2026-04